Citations

Clear

4093 citation(s) found for "Yu, Jonathan".

Health Care Policy and Congenital Heart Disease: 2020 Focus on Our 2030 Future
Chowdhury, Devyani , Johnson, Jonathan N. , Baker‐Smith, Carissa M. , Jaquiss, Robert, Mahendran, Arjun , Curren, Valerie , Bhat, Aarti , Marshall, Audrey C. , Fuller, Stephanie , Marino, Bradley S. , Fink, Christina M. , Ather, Mishaal, Torentinos, Natalie, Kranz, Olivia, Thorne, Vivian, Berger, Stuart, Shaffer, Kenneth M. , Mahendran, Arjun K , Fink, Christina M , Lopez, Keila N , Baker-Smith, Carissa M , Jaquiss, Robert D.B. , Patel, Angira , Lopez, Keila N. , Frank, Lowell H. , Davies, Ryan R. , Snyder, Christopher, Saidi, Arwa S.

Mayo Clinic

Journal of the American Heart Association | October 8, 2021 | Volume: 10 | Issue: 20 | Pages: No page available

10.1161/jaha.120.020605 | PMID 34622676 Get It

Abstract The congenital heart care community faces a myriad of public health issues that act as barriers toward optimum patient outcomes. In this article, we attempt to define advocacy and policy initiatives meant to spotlight and potentially address these challenges. Issues are organized into the following 3 key facets of our community: patient population, health care delivery, and workforce. We discuss the social determinants of health and health care disparities that affect patients in the community that require the attention of policy makers. Furthermore, we highlight the many needs of the growing adults with congenital heart disease and those with comorbidities, highlighting concerns regarding the inequities in access to cardiac care and the need for multidisciplinary care. We also recognize the problems of transparency in outcomes reporting and the promising application of telehealth. Finally, we highlight the training of providers, measures of productivity, diversity in the workforce, and the importance of patient–family centered organizations in advocating for patients. Although all of these issues remain relevant to many subspecialties in medicine, this article attempts to illustrate the unique needs of this population and highlight ways in which to work together to address important opportunities for change in the cardiac care community and beyond. This article provides a framework for policy and advocacy efforts for the next decade.
A High-Sensitivity International Knee Documentation Committee Survey Index From the PROMIS System: The Next-Generation Patient-Reported Outcome for a Knee Injury Population
Robins, Richard J. , Sheean, Andrew J. , Dekker, Travis J. , Collaborative, MOTION, Bailey, James R. , Bharmal, Husain, Bradley, Matthew W. , Cameron, Kenneth L. , Burns, Travis C. , Freedman, Brett A. , Grenier, Eric, Haley, Chad A., Hurvitz, Andrew P. , Mauntel, Timothy C. , McDonald, Lucas S. , Nesti, Leon J. , Posner, Matthew, Provencher, Matthew T. , Roach, Christopher J., Slabaugh, Mark A. , Tucker, Christopher J. , Volk, William R., Dickens, Jonathan F. , Dickens, Jonathan F , Tenan, Matthew S. , Collaborative, MOTION, Galvin, Joseph W. , LeClere, Lance E. , Lee, Ian , Owens, Brett D. , Potter, Benjamin Kyle , Rhon, Daniel I. , Ryan, Paul M. , Schmitz, Matthew R.

Mayo Clinic

The American Journal of Sports Medicine | October 6, 2021 | Volume: 49 | Issue: 13 | Pages: 3561-3568

10.1177/03635465211041593 | PMID 34612705 Get It

Background: Patient-reported outcomes (PROs) measure progression and quality of care. While legacy PROs such as the International Knee Documentation Committee (IKDC) survey are well-validated, a lengthy PRO creates a time burden on patients, decreasing adherence. In recent years, PROs such as the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function and Pain Interference surveys were developed as computer adaptive tests, reducing time to completion. Previous studies have examined correlation between legacy PROs and PROMIS; however, no studies have developed effective prediction models utilizing PROMIS to create an IKDC index. While the IKDC is the standard knee PRO, computer adaptive PROs offer numerous practical advantages. Purpose: To develop a nonlinear predictive model utilizing PROMIS Physical Function and Pain Interference to estimate IKDC survey scores and examine algorithm sensitivity and validity. Study Design: Cohort study (diagnosis); Level of evidence, 3. Methods: The MOTION (Military Orthopaedics Tracking Injuries and Outcomes Network) database is a prospectively collected repository of PROs and intraoperative variables. Patients undergoing knee surgery completed the IKDC and PROMIS surveys at varying time points. Nonlinear multivariable predictive models using Gaussian and beta distributions were created to establish an IKDC index score, which was then validated using leave-one-out techniques and minimal clinically important difference analysis. Results: A total of 1011 patients completed the IKDC and PROMIS Physical Function and Pain Interference, providing 1618 complete observations. The algorithms for the Gaussian and beta distribution were validated to predict the IKDC (Pearson = 0.84-0.86; R 2 = 0.71-0.74; root mean square error = 9.3-10.0). Conclusion: The publicly available predictive models can approximate the IKDC score. The results can be used to compare PROMIS Physical Function and Pain Interference against historical IKDC scores by creating an IKDC index score. Serial use of the IKDC index allows for a lower minimal clinically important difference than the conventional IKDC. PROMIS can be substituted to reduce patient burden, increase completion rates, and produce orthopaedic-specific survey analogs.
Tracking Blood Pressure Control Performance and Process Metrics in 25 US Health Systems: The PCORnet Blood Pressure Control Laboratory
Cooper‐DeHoff, Rhonda M. , Fontil, Valy, Carton, Thomas, Chamberlain, Alanna M. , Todd, Jonathan, O’Brien, Emily C., Shaw, Kathryn M., Smith, Myra, Choi, Sujung, Nilles, Ester K., Ford, Daniel, Tecson, Kristen M. , Dennar, Princess E., Wu, Shenghui, McClay, James C. , Azar, Kristen , Singh, Rajbir, Modrow, Madelaine Faulkner, Shay, Christina M., Wozniak, Gregory, Pletcher, Mark J. , Nilles, Ester Kim , Modrow, Madelaine Faulkner , Ahmad, Faraz , McClay, James , Azar, Kristen , Rakotz, Michael , Pletcher, Mark J , Chamberlain, Alanna M , Faulkner Modrow, Madelaine , Cooper‐DeHoff, Rhonda M. , Fontil, Valy, Carton, Thomas, Todd, Jonathan, O’Brien, Emily C., Shaw, Kathryn M., Smith, Myra, Choi, Sujung, Ford, Daniel, Tecson, Kristen M. , Dennar, Princess E., Wu, Shenghui, Singh, Rajbir, Shay, Christina M., Wozniak, Gregory

Mayo Clinic

Journal of the American Heart Association | October 6, 2021 | Volume: 10 | Issue: 21 | Pages: No page available

10.1161/jaha.121.022224 | PMID 34612048 Get It

Background The National Patient‐Centered Clinical Research Network Blood Pressure Control Laboratory Surveillance System was established to identify opportunities for blood pressure (BP) control improvement and to provide a mechanism for tracking improvement longitudinally. Methods and Results We conducted a serial cross‐sectional study with queries against standardized electronic health record data in the National Patient‐Centered Clinical Research Network (PCORnet) common data model returned by 25 participating US health systems. Queries produced BP control metrics for adults with well‐documented hypertension and a recent encounter at the health system for a series of 1‐year measurement periods for each quarter of available data from January 2017 to March 2020. Aggregate weighted results are presented overall and by race and ethnicity. The most recent measurement period includes data from 1 737 995 patients, and 11 956 509 patient‐years were included in the trend analysis. Overall, 15% were Black, 52% women, and 28% had diabetes. BP control (<140/90 mm Hg) was observed in 62% (range, 44%–74%) but varied by race and ethnicity, with the lowest BP control among Black patients at 57% (odds ratio, 0.79; 95% CI, 0.66–0.94). A new class of antihypertensive medication (medication intensification) was prescribed in just 12% (range, 0.6%–25%) of patient visits where BP was uncontrolled. However, when medication intensification occurred, there was a large decrease in systolic BP (≈15 mm Hg; range, 5–18 mm Hg). Conclusions Major opportunities exist for improving BP control and reducing disparities, especially through consistent medication intensification when BP is uncontrolled. These data demonstrate substantial room for improvement and opportunities to close health equity gaps.
The effect of omega-3 fatty acids on a biomarker of head trauma in NCAA football athletes: a multi-site, non-randomized study
Anzalone, Anthony J. , Carbuhn, Aaron F. , Askow, Andrew T. , Stone, Jason D. , Turner, Stephanie M., Hillyer, Lyn M., Luedke, Joel, Oliver, Jonathan M. , Anzalone, Anthony J , Askow, Andrew T , Heileson, Jeffery L. , W.L., David , Jagim, Andrew R.

Mayo Clinic

Journal of the International Society of Sports Nutrition | September 27, 2021 | Volume: 18 | Issue: 1 | Pages: No page available

10.1186/s12970-021-00461-1 | PMID 34579748 Get It

Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities
Syrjanen, Jeremy A. , Campbell, Michelle R. , Algeciras‐Schimnich, Alicia , Vemuri, Prashanthi , Graff‐Radford, Jonathan, Bu, Guojun , Jack, Clifford R. , Petersen, Ronald C. , Algeciras-Schimnich, Alicia , Jack, Clifford R , Vemuri, Prashanthi , Bu, Guojun , Graff‐Radford, Jonathan , Machulda, Mary M. , Knopman, David S. , Mielke, Michelle M.

Mayo Clinic

Alzheimer's & Dementia | September 27, 2021 | Volume: 18 | Issue: 6 | Pages: 1128-1140

10.1002/alz.12466 | PMID 34569696 Get It

AbstractIntroductionBlood‐based biomarkers of amyloid pathology and neurodegeneration are entering clinical use. It is critical to understand what factors affect the levels of these markers.MethodsPlasma markers (Aβ42, Aβ40, NfL, T‐tau, Aβ42/40 ratio) were measured on the Quanterix Simoa HD‐1 analyzer for 996 Mayo Clinic Study of Aging (MCSA) participants, aged 51 to 95 years. All other data were collected during in‐person MCSA visits or abstracted from the medical record.ResultsAmong cognitively unimpaired (CU) participants, all plasma markers correlated with age. Linear regression models revealed multiple relationships. For example, higher Charlson Comorbidity Index and chronic kidney disease were associated with higher levels of all biomarkers. Some relationships differed between mild cognitive impairment and dementia participants.DiscussionMultiple variables affect plasma biomarkers of amyloid pathology and neurodegeneration among CU in the general population. Incorporating this information is critical for accurate interpretation of the biomarker levels and for the development of reference ranges.
Validating a Computable Phenotype for Nephrotic Syndrome in Children and Adults Using PCORnet Data
Oliverio, Andrea L. , Marchel, Dorota, Troost, Jonathan P. , Ayoub, Isabelle , Almaani, Salem , Greco, Jessica, Tran, Cheryl L., Denburg, Michelle R., Matheny, Michael E. , Dorn, Chad, Massengill, Susan F. , Desmond, Hailey, Greco, Jessica , Matheny, Michael , Gipson, Debbie S , Oliverio, Andrea L. , Marchel, Dorota, Troost, Jonathan P. , Ayoub, Isabelle , Almaani, Salem , Tran, Cheryl L., Denburg, Michelle R., Dorn, Chad, Massengill, Susan F. , Desmond, Hailey, Mariani, Laura H.

Mayo Clinic

Kidney360 | September 27, 2021 | Volume: 2 | Issue: 12 | Pages: 1979-1986

10.34067/kid.0002892021 | PMID 35419531 Get It

Key Points A computable phenotype combines routinely collected data elements from the EHR with logic elements to identify a condition of interest. This validated computable phenotype has strong classification characteristics to identify individuals with primary nephrotic syndrome. This computable phenotype for primary nephrotic syndrome can facilitate future research of these rare diseases. Background Primary nephrotic syndromes are rare diseases which can impede adequate sample size for observational patient-oriented research and clinical trial enrollment. A computable phenotype may be powerful in identifying patients with these diseases for research across multiple institutions. Methods A comprehensive algorithm of inclusion and exclusion ICD-9 and ICD-10 codes to identify patients with primary nephrotic syndrome was developed. The algorithm was executed against the PCORnet CDM at three institutions from January 1, 2009 to January 1, 2018, where a random selection of 50 cases and 50 noncases (individuals not meeting case criteria seen within the same calendar year and within 5 years of age of a case) were reviewed by a nephrologist, for a total of 150 cases and 150 noncases reviewed. The classification accuracy (sensitivity, specificity, positive and negative predictive value, F1 score) of the computable phenotype was determined. Results The algorithm identified a total of 2708 patients with nephrotic syndrome from 4,305,092 distinct patients in the CDM at all sites from 2009 to 2018. For all sites, the sensitivity, specificity, and area under the curve of the algorithm were 99% (95% CI, 97% to 99%), 79% (95% CI, 74% to 85%), and 0.9 (0.84 to 0.97), respectively. The most common causes of false positive classification were secondary FSGS (nine out of 39) and lupus nephritis (nine out of 39). Conclusion This computable phenotype had good classification in identifying both children and adults with primary nephrotic syndrome utilizing only ICD-9 and ICD-10 codes, which are available across institutions in the United States. This may facilitate future screening and enrollment for research studies and enable comparative effectiveness research. Further refinements to the algorithm including use of laboratory data or addition of natural language processing may help better distinguish primary and secondary causes of nephrotic syndrome.
Does reduction of the Meyerding grade correlate with outcomes in patients undergoing decompression and fusion for grade I degenerative lumbar spondylolisthesis?
Chan, Andrew K. , Mummaneni, Praveen V. , Burke, John F. , Mayer, Rory , Bisson, Erica F. , Rivera, Joshua, Pennicooke, Brenton , Fu, Kai-Ming, Park, Paul , Bydon, Mohamad , Glassman, Steven D. , Foley, Kevin T. , Shaffrey, Christopher I. , Potts, Eric A. , Shaffrey, Mark E., Coric, Domagoj , Knightly, John J. , Wang, Michael Y. , Slotkin, Jonathan R., Asher, Anthony L. , Virk, Michael S. , Kerezoudis, Panagiotis , Alvi, Mohammed Ali , Haid, Regis W., Chou, Dean , Alvi, Mohammed A, Alvi, Mohammed Ali , Guan, Jian

Mayo Clinic

Journal of Neurosurgery: Spine | September 25, 2021 | Volume: 36 | Issue: 2 | Pages: 177-184

10.3171/2021.3.spine202059 | PMID 34534963 Get It

OBJECTIVE Reduction of Meyerding grade is often performed during fusion for spondylolisthesis. Although radiographic appearance may improve, correlation with patient-reported outcomes (PROs) is rarely reported. In this study, the authors’ aim was to assess the impact of spondylolisthesis reduction on 24-month PRO measures after decompression and fusion surgery for Meyerding grade I degenerative lumbar spondylolisthesis. METHODS The Quality Outcomes Database (QOD) was queried for patients undergoing posterior lumbar fusion for spondylolisthesis with a minimum 24-month follow-up, and quantitative correlation between Meyerding slippage reduction and PROs was performed. Baseline and 24-month PROs, including the Oswestry Disability Index (ODI), EQ-5D, Numeric Rating Scale (NRS)–back pain (NRS-BP), NRS-leg pain (NRS-LP), and satisfaction (North American Spine Society patient satisfaction questionnaire) scores were noted. Multivariable regression models were fitted for 24-month PROs and complications after adjusting for an array of preoperative and surgical variables. Data were analyzed for magnitude of slippage reduction and correlated with PROs. Patients were divided into two groups: < 3 mm reduction and ≥ 3 mm reduction. RESULTS Of 608 patients from 12 participating sites, 206 patients with complete data were identified in the QOD and included in this study. Baseline patient demographics, comorbidities, and clinical characteristics were similarly distributed between the cohorts except for depression, listhesis magnitude, and the proportion with dynamic listhesis (which were accounted for in the multivariable analysis). One hundred four (50.5%) patients underwent lumbar decompression and fusion with slippage reduction ≥ 3 mm (mean 5.19, range 3 to 11), and 102 (49.5%) patients underwent lumbar decompression and fusion with slippage reduction < 3 mm (mean 0.41, range 2 to −2). Patients in both groups (slippage reduction ≥ 3 mm, and slippage reduction < 3 mm) reported significant improvement in all primary patient reported outcomes (all p < 0.001). There was no significant difference with regard to the PROs between patients with or without intraoperative reduction of listhesis on univariate and multivariable analyses (ODI, EQ-5D, NRS-BP, NRS-LP, or satisfaction). There was no significant difference in complications between cohorts. CONCLUSIONS Significant improvement was found in terms of all PROs in patients undergoing decompression and fusion for lumbar spondylolisthesis. There was no correlation with clinical outcomes and magnitude of Meyerding slippage reduction.
Titanium Cervical Cage Subsidence: Postoperative Computed Tomography Analysis Defining Incidence and Associated Risk Factors
Pinter, Zachariah W. , Reed, Ryder, Townsley, Sarah E., Mikula, Anthony L. , Dittman, Lauren E. , Xiong, Ashley , Skjaerlund, Jonathan, Michalopoulos, Giorgos D. , Currier, Bradford L. , Fogelson, Jeremy L. , Freedman, Brett A. , Bydon, Mohamad , Kepler, Christopher K. , Wagner, Scott C. , Elder, Benjamin D. , Sebastian, Arjun S. , Dittman, Lauren, Freedman, Brett A , Bydon, Mohamad , Michalopoulos, Giorgos , Nassr, Ahmad

Mayo Clinic

Global Spine Journal | September 24, 2021 | Volume: 13 | Issue: 7 | Pages: 1703-1715

10.1177/21925682211046897 | PMID 34558320 Get It

Study Design Retrospective cohort study Objective Substantial variability in both the measurement and classification of subsidence limits the strength of conclusions that can be drawn from previous studies. The purpose of this study was to precisely characterize patterns of cervical cage subsidence utilizing computed tomography (CT) scans, determine risk factors for cervical cage subsidence, and investigate the impact of subsidence on pseudarthrosis rates. Methods We performed a retrospective review of patients who underwent one- to three-levels of anterior cervical discectomy and fusion (ACDF) utilizing titanium interbodies with anterior plating between the years 2018 and 2020. Subsidence measurements were performed by two independent reviewers on CT scans obtained 6 months postoperatively. Subsidence was then classified as mild if subsidence into the inferior and superior endplate were both ≤2 mm, moderate if the worst subsidence into the inferior or superior endplate was between 2 to 4 mm, or severe if the worst subsidence into the inferior or superior endplate was ≥4 mm. Results A total of 51 patients (100 levels) were included in this study. A total of 48 levels demonstrated mild subsidence (≤2 mm), 38 demonstrated moderate subsidence (2-4 mm), and 14 demonstrated severe subsidence (≥4 mm). Risk factors for severe subsidence included male gender, multilevel constructs, greater mean vertebral height loss, increased cage height, lower Taillard index, and lower screw tip to vertebral body height ratio. Severe subsidence was not associated with an increased rate of pseudarthrosis. Conclusion Following ACDF with titanium cervical cages, subsidence is an anticipated postoperative occurrence and is not associated with an increased risk of pseudarthrosis.
Radiomics Derived Brain Age Predicts Functional Outcome After Acute Ischemic Stroke
Bretzner, Martin , Bonkhoff, Anna K. , Schirmer, Markus D. , Hong, Sung‐Min , Donahue, Kathleen, Etherton, Mark R. , Rist, Pamela M. , Nardin, Marco, Regenhardt, Robert W. , Leclerc, X. , Gautherot, Morgan , Wang, Clinton, Benavente, Oscar, Donatti, Amanda , Heitsch, Laura , Jiménez-Conde, Jordi , Kittner, Steven J. , McArdle, Patrick, Rolfs, Arndt , Schmidt, Reinhold, Sharma, Pankaj , Słowik, Agnieszka , Sousa, Alessandro Viana Oliveira e, Strbian, Daniel , Wassélius, Johan , Woo, Daniel , Worrall, Bradford B. , Maguire, Jane , Golland, Polina , Kuchcinski, Grégory , Rost, Natalia S. , Bretzner, Martin , Strbian, Daniel , Regenhardt, Robert W , Dalca, Adrian Vasile , Giese, Anne‐Katrin , Lopes, Renaud , Cole, John W. , Griessenauer, Christoph J. , Holmegaard, Lukas , Jood, Katarina , Lemmens, Robin , Levi, Christopher , McDonough, Caitrin W. , Meschia, James F. , Phuah, Chia‐Ling , Ropele, Stefan , Rosand, Jonathan M. , Roquer, Jaume , Rundek, Tatjana , Sacco, Ralph L. , Sousa, Alessandro Augusto Viana Oliveira e, Stanne, Tara M. , Tatlisumak, Turgut , Thijs, Vincent , Vagal, Achala , Wu, Ona , Zand, Ramin , Lindgren, Arne G. , Jern, Christina

Mayo Clinic

No container title available | September 24, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-923769/v1 Get It

Abstract While chronological age is one of the most influential determinants of post-stroke outcomes, little is known of the impact of neuroimaging-derived biological brain age. We here first examine whether radiomics analysis of the texture of brain T2-FLAIR MRI images can be used to predict brain age in stroke patients. We then assess the clinical determinants of accelerated brain aging and, finally, its impact on post-stroke functional outcomes. Leveraging a multisite cohort of 4,163 ischemic stroke patients, we show that older-appearing patients have more hypertension, diabetes mellitus, prior strokes, and smoking history and are more likely to develop worse post-stroke outcomes than their younger-appearing counterparts. Our results strengthen the importance of preventive medicine for maintaining brain health in stroke patients as they age and suggest a novel methodology to capture previously undescribed prognostic information available on commonly acquired MRI sequences during routine stroke care.